Raghu S Pandurangi (Raghu Pandurangi)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Cancer Stem Cells

Top Venues

Journal of medicinal chemistry

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Raghu S Pandurangi, Thillai Sekar, Ramasamy Paulmurugan
Restoration of the Lost Human Beta Defensin-1 Protein in Cancer as a Strategy to Improve the Efficacy of Chemotherapy. Journal of medicinal chemistry 67 (16) (2024)
Raghu S Pandurangi, Thillai Sekar, Ramasamy Paulmurugan
Restoration of the Lost Human Beta Defensin-1 Protein in Cancer as a Strategy to Improve the Efficacy of Chemotherapy. Journal of medicinal chemistry (2024)
Raghu S Pandurangi, Thillai Sekar, Ramasamy Paulmurugan
Restoration of the Lost Human Beta Defensin-1 Protein in Cancer as a Strategy to Improve the Efficacy of Chemotherapy. Journal of medicinal chemistry 67 (16) (2024)
Raghu S Pandurangi, Thillai Sekar, Ramasamy Paulmurugan
Restoration of the Lost Human Beta Defensin-1 Protein in Cancer as a Strategy to Improve the Efficacy of Chemotherapy. Journal of medicinal chemistry (2024)
Raghu S Pandurangi, Orsolya Cseh, Hema Artee Luchman, Cynthia Xiuguang Ma, Sanjeewa N Senadheera, Marcus Laird Forrest
Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin. ACS pharmacology & translational science 6 (3) (2023)
Raghu S Pandurangi, Orsolya Cseh, Hema Artee Luchman, Cynthia Xiuguang Ma, Sanjeewa N Senadheera, Marcus Laird Forrest
Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin. ACS pharmacology & translational science 6 (3) (2023)
Raghu S Pandurangi, Marco Tomasetti, Sekar T Verapazham, Ramasamy Paulmurugan, Cynthia Ma, Sandeep Rajput, Manjushree Anjanappa, Harikrishna Nakshatri
A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment. PloS one 16 (2) (2021)